FAQ Contact UsRegister »
+ Reply to Thread
Results 1 to 1 of 1
  1. 03-31-2016 10:46 AM #1
    lurker77
    lurker77 is offline
    Junior Member
    Join Date
    Aug 2012
    Posts
    11

    Default Aclaris aquires Vixen (JAK inhibitor research)

    One article here. Aclaris is a NASDAQ traded company with an estimated value of $55M and an estimated market cap of $350M.

    Edit: Basically a repost, can't find a way to delete.
    Reply With Quote Reply With Quote
« Previous Thread | Next Thread »

Similar Threads

  1. Homemade PGD2 Inhibitor
    By sksingh91 in forum Hair Loss Treatments
    Replies: 58
    Last Post: 02-07-2018, 02:19 AM
  2. Aclaris buy Vixen rights
    By candu2015 in forum Cutting Edge / Future Treatments
    Replies: 9
    Last Post: 04-03-2016, 10:40 AM
  3. Follicum research results will be presented at the World Congress for Hair Research
    By Tenma in forum Techniques in Possible Donor Regeneration and Multiplication
    Replies: 2
    Last Post: 10-05-2015, 10:02 AM
  4. Evolis?? FGF-5 inhibitor already in the market!!
    By lacazette in forum Hair Loss Treatments
    Replies: 3
    Last Post: 06-22-2015, 09:30 AM
  5. Has anyone used an Aromatase inhibitor while on Finasteride?
    By goldnt in forum Men's Hair Loss: Start Your Own Topic
    Replies: 0
    Last Post: 09-13-2014, 07:22 PM

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

Forum Rules

» IAHRS

hair transplant surgeons

» The Bald Truth

» americanhairloss.org

» Recent Threads